Evidence map›Paper›PMID 32183153›Full record

ArticleMolecules (Basel, Switzerland)2020

Cytotoxic Evaluation and Anti-Angiogenic Effects of Two Furano-Sesquiterpenoids from

Ali S Alqahtani, Fahd A Nasr, Omar M Noman, Muhammad Farooq, Tariq Alhawassi, Wajhul Qamar, Ali El-Gamal

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Effect of NaturalToxics · 2022
    Article
  8. Article
  9. Article
  10. Plants (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Phytochemical constituents and anticancer activities ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ali S AlqahtaniDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-1034-7441
Fahd A NasrMedicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-6496-7822
Omar M NomanMedicinal, Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-0902-6381
Muhammad FarooqBioproducts Research Chair, College of Science, Department of Zoology, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-9891-2443
Tariq AlhawassiMedication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Wajhul QamarCentral Laboratory, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Ali El-GamalDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Funding

King Saud University RSP-2019/67
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAnimalsApoptosisCell Cycle CheckpointsCell LineCommiphoraEmbryonic DevelopmentEmbryo, NonmammalianFuransHumansInhibitory Concentration 50NecrosisNeovascularization, PhysiologicResins, PlantSesquiterpenesZebrafishAngiogenesis InhibitorsFuransmyrrh resinResins, PlantSesquiterpenesangiogenesisapoptosiscell cyclecommiphora myrrhfurano-sesquiterpenoidszebrafish

Identifiers

PMID32183153
PMCPMC7144466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.